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The removal of apoptotic cells by phagocytic neigh-
bors is essential for metazoan development but
remains poorly characterized. Herewe report the dis-
covery of a Drosophila phagocytosis receptor, Six-
microns-under (SIMU), which is expressed in highly
phagocytic cell types during development and re-
quired for efficient apoptotic cell clearance by glia
in the nervous system and by macrophages else-
where. SIMU is part of a conserved family of proteins
that includes CED-1 and Draper (DRPR). Phenotypic
analysis reveals that simu acts upstream of drpr in
the same pathway and affects the recognition and
engulfment of apoptotic cells, while drpr affects their
subsequent degradation. SIMU strongly binds to
apoptotic cells, presumably through its EMILIN-like
domain, but requires no membrane anchoring, sug-
gesting that it can function as a bridging molecule.
Our study introduces an important factor in tissue-
resident apoptotic clearance and underscores the
prominent role of glia as ‘‘semiprofessional’’ phago-
cytes in the nervous system.
INTRODUCTION
The elimination of superfluous or damaged cells through
programmed cell death plays an essential role in metazoan de-
velopment and tissue homeostasis; its critical final stage is the
clearance of the apoptotic cells through phagocytosis. The
proper recognition, uptake, and degradation of dying cells is
accomplished either by ‘‘professional’’ phagocytes, such as
macrophages and immature dendritic cells, or by ‘‘nonprofes-
sional’’ tissue-resident neighboring cells. While professional
phagocytes have been studied extensively, relatively little is
known about the biological significance and the molecular
underpinnings of tissue-resident phagocytosis (Henson and
Hume, 2006).
Apoptotic cell clearance is a complex process, involving
recognition, engulfment, phagosome formation and maturation
as distinct steps (Figure 1E) (for review, see Grimsley and498 Cell 133, 498–509, May 2, 2008 ª2008 Elsevier Inc.Ravichandran, 2003; Stuart and Ezekowitz, 2005). The apoptotic
cell displays distress (‘‘eat me’’) signals that are recognized by
the phagocyte, either directly by phagocytic receptors or indi-
rectly through bridging molecules (opsonins), supplied systemi-
cally through the serum or secreted locally by the phagocyte.
Two types of phagocytic receptors have been implicated in
this recognition process: tethering receptors without a significant
intracellular domain, such as CD36 (Franc et al., 1999; Savill
et al., 1992) or SRA (Platt andGordon, 1998), and docking recep-
tors with noncatalytic intracellular domains permitting interaction
with other proteins, such as CED-1 and its homolog Draper
(DRPR) (Freeman et al., 2003; Zhou et al., 2001), or LRP (Ogden
et al., 2001). The clustering of both types of receptors is thought
to be required for the recruitment of the downstream machinery
to the docking sites, which leads to cytoskeletal reorganization
and engulfment of the apoptotic cell. The phagocytosis process
is completed by the formation of a phagosome and its matura-
tion to a phagolysosome, effecting the degradation of the
apoptotic particle.
Insight into the molecular mechanisms by which nonprofes-
sional tissue-resident cells effect apoptotic clearance came
initially from the worm, which does not have professional phago-
cytes. Genetic screens identified several phagocytosis genes
that fall into two partially redundant pathways: one consists of
a phagocytic docking receptor (CED-1), its adapter (CED-6), an
ABC transporter (CED-7), and dynamin; the other pathway con-
sists of an actin-regulating protein complex (CED-2/5/10/12) that
presumably acts downstreamof anunknownphagocytic receptor
(for review, see Mangahas and Zhou, 2005; Reddien and Horvitz,
2004; Yu et al., 2006). Recently, the phosphatidylserine receptor
BAI1 was found to act upstream of the homologous complex in
mouse (Park et al., 2007). In Drosophila, only three factors have
been implicated in apoptotic cell clearance to date: the macro-
phage-specific CD36 homolog Croquemort (CRQ) (Franc et al.,
1999), the F Box protein Pallbearer (Silva et al., 2007), and the
broadly expressed CED-1 homolog DRPR, which plays a role in
glial phagocytosis of apoptotic neurons (Freeman et al., 2003). A
recent study suggests that the apoptotic clearance function of
CED-1/DRPR is conserved in vertebrates (Hamon et al., 2006).
Thus, most of the players involved in tissue-resident clearance
are still unknown, in particular the phagocytic receptors and their
cognate ligands on the apoptotic cell. More generally, a better
understanding of the cellular and molecular underpinnings of
Figure 1. Apoptosis and Glial Phagocytosis in Late Nervous System Development
(A) Lateral view of a CM1-stained stage 16 embryo, showing that at this developmental stage apoptosis is largely restricted to the CNS (arrows).
(B and C) Ventral and transverse (from dashed area in B) views of CNS (ELAV, pink), showing that macrophages (CRQ, green) hover around it without entering.
(D) Schematic of transverse section through CNS, showing the positions of astrocytic cell body glia and macrophages; gray box indicates position of confocal
sections shown in (F)–(H).
(E) Schematic depicting the different stages of phagocytosis: apopotic cell recognition, engulfment, phagosome formation and maturation.
(F–H) Ventral view of CNS in confocal stacks, showing membrane-labeled glia (repo::CD8GFP, green) and different apoptosis/phagocytosis markers (red): (F)
AnnexinV as an early apoptosis marker, (G) activated caspase-3 (CM1) as a later apoptosis marker, and (H) LysoTracker as a phagosome maturation marker.
Circles in (F) highlight unengulfed cells with high levels of AnnexinV staining.apoptotic clearance in vivo is highly desirable. In the work pre-
sented here, we demonstrate that glia are the main phagocytes
in the late developing nervous system of the fly. We describe
a new tethering receptor named Six-microns-under (SIMU),
which functions in apoptotic clearance by both glia and macro-
phages, and find that it acts upstream of DRPR in the same path-
way. Our study reveals an evolutionary expansion and concom-
itant specialization of the repertoire of CED-1-like receptors, with
SIMU required for the recognition and engulfment, and DRPR for
the degradation of corpses.
RESULTS
Glia Clear Apoptotic Neurons in Late Embryogenesis
In Drosophila development, the elimination of superfluous cells
through apoptosis occurs in three main phases: first in mid-to-
late embryogenesis, then in midpupa, and again in the early
adult. Much of the cell death occurs in the nervous system,
where almost half the cells are removed (Abrams et al., 1993;
Rogulja-Ortmann et al., 2007). Apoptotic cell clearance in em-
bryogenesis was originally thought to be performed primarily
by professional phagocytes, the macrophages (Franc et al.,
1999; Sonnenfeld and Jacobs, 1995), but more recent work
(Freeman et al., 2003; Mergliano and Minden, 2003), including
ours presented here, shows that both the ectoderm and the
glia are avid phagocytes in their own right.
When tracking apoptosis in the embryonic nervous system
with activated caspase antibodies (CM1) we observe a highand steady amount of neuronal cell death between 13 and
16 hr of development (stage 16; Figure 1A) (Rogulja-Ortmann
et al., 2007). By this stage, the ventral nerve cord is ensheathed
by an epithelium formed by surface glia (Schwabe et al., 2005),
and macrophages are found hovering around the nerve cord
without entering it (Figures 1B and 1C). When we examine the
neural cortex, the portion of the nerve cord that harbors the neu-
ronal cell bodies and where most apoptosis takes place
(Figure 1D), we find that nearly all CM1-positive apoptotic parti-
cles are either engulfed or at least touched by neighboring glia,
which are visualized using a transgenic glial membrane marker
(repo::CD8GFP) (Figure 1G) (cf. Sonnenfeld and Jacobs, 1995).
This suggests that in normal tissue the activation of effector cas-
pase is concurrent with phagocytic uptake and thus relatively
late. Based on their morphology and position, the CNS glia fall
into three main categories: glia that ensheathe the axon tracts
(‘‘neuropile glia’’), glia that ensheathe the nerve cord as a whole
(‘‘surface glia’’), and astrocyte-like glia residing in the neural
cortex (‘‘cell body glia’’) (Ito et al., 1995). These cell body glia ap-
pear to be the principal phagocytes in the nervous system at later
stages of embryonic development. Unlike vertebrates, the Dro-
sophila nervous system does not contain microglia, which are
blood-derived but tissue-resident professional macrophages.
The phagocytic role of glia is corroborated by live observation
with additional death and phagocytosis markers. Phosphatidyl-
serine, a phospholipid that is restricted to the inner leaflet of
the plasma membrane in healthy cells, accumulates on the outer
surface during apoptosis (van den Eijnde et al., 1998) and isCell 133, 498–509, May 2, 2008 ª2008 Elsevier Inc. 499
Figure 2. Expression of simu Transcript and Protein Fusions
(A–C) RNA in situ hybridization (simuORF as probe) of wholemount embryos showing simu transcript accumulation in the ectoderm (A; lateral view, stage 13), the
macrophages (B; ventral view, stage 14), and the astrocytic cell body glia (C; ventral views, stage 16).
(D) Northern analysis (simuORF as probe), showing a single 1.3 kb simu transcript with strong expression in mid and late embryogenesis, no expression in larvae,
strong expression in midpupae, and weak expression in adults, particularly heads.
(E–J) This expression is confirmed using MYC-tagged SIMU (green) under simu promoter control (see Figure 5A) and cell type-specific markers (red): CRQ for
macrophages (F and G), and REPO for glia (I and J). Arrowheads (H and J) indicate SIMU-positive but REPO-negative macrophages outside the CNS.
(K–P) C-terminally GFP-tagged SIMU expressed in S2 cells localizes to the plasmamembrane as visualized by live GFP fluorescence (K and N), but the GFP tag is
recognized by antibody only after detergent treatment (compare L and O).
(Q and R) Expression of SIMU-GFP in ectodermal stripes in the embryo (prd-Gal4 driver) also shows cell surface expression; overlay with prd::mRFP in (R).recognized with high affinity by AnnexinV. When fluorescent An-
nexinV probe is injected into embryos that express the glial
membrane marker (repo::CD8GFP), we find most of the strongly
AnnexinV-positive particles touched or engulfed by the glia, but
a significant fraction remains untouched (Figure 1F), suggesting
that AnnexinV is an earlier or more sensitive marker for apoptosis
than activated caspase CM1 antibody (Figure 1G). By contrast,
when lysosomal activity is monitored in vivo by injecting fluores-
cent LysoTracker, we find that nearly all lysosomal activity in the
nerve cord coincides with the glia (Figure 1H). In embryos lacking
apoptosis, all three markers show accordant changes in their
distribution (Figure S1). Multiple independent markers thus indi-
cate that the removal of apoptotic cells in the nerve cord is en-
tirely carried out by the tissue-resident glial cells. This finding is
consistent with results of a genome-wide transcription profiling
of FACS-sorted embryonic glia, in which phagocytosis genes
are highly represented, including homologs of vertebrate phago-
cytic receptors, DRPR, and other orthologs of the two worm
phagocytosis pathways (H. Courvoisier, D. L., J. Fak, N. Rajew-
sky, and U. G., unpublished data).
The simu Gene Is Expressed in All Three Phagocytic
Cell Populations
To begin our molecular and genetic investigation of glial phago-
cytosis, we focused on a new gene we named six-microns-under500 Cell 133, 498–509, May 2, 2008 ª2008 Elsevier Inc.(simu, = CG16876), which ranked near the top in our glial tran-
scription profile and whose expression and molecular features
made it a particularly promising candidate. Northern analysis
shows a dynamic expression of simu, which parallels the main
epochs of developmental apoptosis: mid-to-late embryogene-
sis, pupa, and young adult. It is also expressed in the adult ner-
vous system (Figure 2D). RNA in situ hybridization reveals that
simu is expressed specifically in all three phagocytic cell popula-
tions: at midembryogenesis (stages 10–15), it is found in macro-
phages and the ectoderm (Figures 2A and 2B), and later on
(stage 16) also in the glia, with the strongest expression in the
astrocytic cell body glia (Figure 2C). This intriguing expression
pattern suggested an involvement of simu in the phagocytosis
of apoptotic cells.
We identified a 2 kb genomic fragment upstream of the simu
translation start site, which, when fused to a cytoplasmic GFP re-
porter (simu-cytGFP), recapitulates the endogenous expression
pattern of the locus, namely expression in ectoderm, macro-
phages, and glia. We use this simu-cytGFP reporter in some of
our descriptive and genetic analysis, in particular our time-lapse
recordings of phagocytosis in vivo (see below). Since we have
not been able to generate SIMU antibodies (the protein is very dif-
ficult to express in bacteria), we also used this 2 kb simu promoter
to drive a SIMU-MYC protein fusion (simu-SIMU-MYC), which
serves as our immunohistochemical marker for SIMU protein
expression in vivo (Figures2E–2J). simu-SIMU-MYCshowsstrong
expression on the cell surface of macrophages and glia, but loses
ectodermal expression earlier than the simu-cytGFP reporter,
suggesting a difference in protein turnover between SIMU and
GFP.
The simu Genomic Null Mutant Shows Impaired
Recognition and Engulfment of Apoptotic Particles
To examine the biological function of simu, we sought to gener-
ate a genomic knockout. Since there are no P insertions in the vi-
cinity of the simu locus (the nearest P element was 40 kb away),
targeted homologous recombination was the only viable strat-
egy. We engineered a simu null allele in which both in-frame
ATGs of the coding region were replaced by stop codons
(Figure 3T) and swapped the mutant version into the endoge-
nous locus (see Experimental Procedures). The success of the
genomic knockout was confirmed both at the molecular level,
by PCR and Southern blot analysis, and genetically—a defi-
ciency uncovering the simu locus (Df(2L)Sco7) fails to comple-
ment our simu null mutant. A genomic fragment containing the
entire transcribed region and 2 kb upstream completely rescues
the simu phenotype (Figure 5B, see below).
simu mutant animals are homozygous viable and show no
gross morphologic abnormalities. To test for phagocytosis de-
fects in vivo, we transgenically labeled the phagocytic cell pop-
ulations (repo::CD8GFP for glia; simu-cytGFP for macrophages);
apoptotic particles were labeled with activated caspase anti-
bodies (CM1). In simumutants, the number, position, and overall
morphology of CNS glia in general and of the highly phagocytic
cell body glia in particular appear normal (average glial cell num-
ber 37.2 ± 5.6, compared to 37.1 ± 3.8 in wild-type, measured in
representative stacks of confocal images, see Experimental Pro-
cedures). However, the clearance of apoptotic cells is markedly
impaired. The number and total volume of apoptotic particles is
increased about 2-fold over wild-type (Figures 3A, 3B, and 3Q),
and the apoptotic particles are much less likely to be engulfed.
The fraction of particles that are completely untouched by glial
cells is increased 3-fold in simu mutants over wild-type (Figures
3E, 3F, and 3R), indicating a significant impairment in the recog-
nition and/or engulfment of apoptotic cells. Similar phenotypes
are observed in macrophage phagocytosis: Again, the number
(44.8 ± 5.0, compared to 46.3 ± 4.3 in wild-type, see Experimen-
tal Procedures), migration pattern, and morphology of the mac-
rophages appear normal. However, the number and volume of
apoptotic particles in the embryo outside the nervous system
is strongly increased (Figure 3S), and many particles remain un-
engulfed, often forming large clusters near the macrophages
(Figures 3I, 3J, 3M, and 3N). These findings point to the same
corpse recognition and engulfment defect as in the glia.
To gain insight into the cellular dynamics, we carried out time-
lapse recordings in live embryos, with simu-cytGFP labeling glia
and macrophages and injected fluorogenic caspase-3 substrate
Phiphilux labeling apoptotic cells (see Experimental Proce-
dures). In wild-type, almost all caspase-3-positive particles are
engulfed or at least touched by a phagocyte, as observed before
in fixed material. Both glia and macrophages are constantly
sending out processes to probe their environment and quickly
engulf apoptotic cells; the macrophages move around at highspeed (1 mm/min) while the glia remain stationary (Figure 4E,
Movie S1). In the simumutant, both search behavior and motility
of the phagocytes are normal, but many apoptotic particles
remain completely untouched for extended periods of time or
are briefly touchedwithout being tethered. In addition, many par-
ticles attach to the phagocyte cell surface without being
engulfed; occasionally, we observe the formation of incomplete
phagocytic cups (Figure 4F, Movie S2). These findings clearly in-
dicate that simu does not influence the general behavior and
morphology of phagocytes, but rather affects specifically their
ability to recognize and engulf apoptotic particles.
Simu Protein Structure and Function
The simu gene is predicted to encode a 377 aa transmembrane
protein, comprising an N-terminal signal peptide, a large extra-
cellular portion, a single putative transmembrane (TM) domain,
and a short cytoplasmic tail at the C terminus (Figure 5A). The
extracellular portion of the protein consists of an N-terminal
EMILIN (EMI)-like domain (Callebaut et al., 2003) and four EGF
domains with highly stereotyped spacing of Cys residues, re-
cently named Nimrod (NIM) repeats (Kurucz et al., 2007). Intrigu-
ingly, the combination of an EMI(-like) domain, with a highly
conserved CC3GY motif at its C-terminal end and immediately
followed by a NIM repeat (Figure 6E), is found across the verte-
brate/invertebrate divide in a small number of both secreted and
transmembrane factors, some of which have been shown to
function in phagocytosis. They include the CED-1 homologs in
all species (DRPR, human MEGF10, mouse Jedi), the fly bacte-
rial phagocytosis factor Eater (Kocks et al., 2005), and the large
Nimrod gene cluster located at 34E (Kurucz et al., 2007), the
most proximal member of which is simu (= NimC4), as well as
human SREC (see Figure S2 for a detailed comparison).
To confirm the overall protein organization of SIMU and deter-
mine its orientation within the plasma membrane, we C-termi-
nally tagged SIMU with GFP and expressed the protein fusion
in Drosophila tissue culture (S2) cells. Live observation detects
SIMU-GFP at the plasma membrane (Figures 2K and 2N); after
fixation, GFP antibodies recognize the fusion protein only when
cells are permeabilized with detergent (Figures 2L and 2O), indi-
cating that the C terminus is intracellular and thus identifying
SIMU as a type I transmembrane protein. Consistent with these
results, both SIMU-GFP and SIMU-MYC localize to the plasma
membrane in the embryo (Figures 2Q and 2R).
Given that the simu phenotype reveals a function in the recog-
nition and engulfment of apoptotic particles, we sought to test
whether the SIMU protein is able to bind to apoptotic cells in
vitro. To this end, we produced a secreted tagged version of
SIMU—comprising the entire extracellular domain of the pro-
tein—in human HEKc18 cells. Strikingly, while affinity-purified
HIS-MYC-SIMUDTM protein shows very little binding to live S2
cells, consistent with the small percentage of dying cells within
the culture, we observe very strong binding to apoptotic S2 cells
(Figure 3U).
Interestingly, SIMU is also sufficient to increase the uptake of
apoptotic cells in a heterologous system: we overexpressed the
protein in COS7 cells using transient transfection (see Experi-
mental Procedures), with GFP as a negative control and the
known tethering receptor CRQ as a positive control (FrancCell 133, 498–509, May 2, 2008 ª2008 Elsevier Inc. 501
Figure 3. Genetic and Phenotypic Analysis of simu and drpr
(A–H) Projections from confocal stacks of neural cortex layer of the CNS at embryonic stage 16, ventral view; apoptotic cells in red (CM1) and glia in green
(repo::CD8GFP). In simu (B and F) and drpr (C and G) null mutants, the number of apoptotic particles almost doubles compared to wild-type (A and E), but
does not increase further in the simu; drpr double mutant (D and H); for quantitation see (Q). In simu mutants the apoptotic cells accumulate outside (circles),
in drpr mutants inside the glia (dotted circles), in the double mutant they accumulate outside (circles); for quantitation see (R).
(I–P) Macrophages (green, simu-cytGFP) show the same phenotypic defects as glia in all genotypes.
(Q–S) Quantification of phenotypic defects: (Q) total number of apoptotic particles within CNS sections; (R) fraction of apoptotic particles that are completely
untouched by glia; (S) volume of apoptotic particles in the embryo outside the CNS (stage 14). Columns representmean values ±SEM, n = 7–12; asterisks indicate
statistical significance versus wild-type, as determined by one-way ANOVA, with Student-Newmann-Keuls post hoc test, ***p < 0.001, **p < 0.01.
(T) Schematic of the simu genomic region and of the simu knockout targeting construct.
(U) Flow cytometric analysis of MYC-SIMUDTM protein binding to S2 cells. Apoptotic S2 cells (bottom) are strongly bound by SIMU; live cells (top) are not.et al., 1996). Compared to GFP-transfected cells, SIMU-trans-
fected cells showed amodest increase in the uptake of apoptotic
cells (1.3-fold), very similar to that of CRQ (1.4-fold). Taken502 Cell 133, 498–509, May 2, 2008 ª2008 Elsevier Inc.together, these data complement the results of our in vivo anal-
ysis and provide further strong evidence for a role of SIMU in the
recognition and uptake of apoptotic particles.
In Vivo Analysis of SIMU Protein Truncations
To gain further insight into themolecular function of SIMU, we re-
moved portions of the protein and examined whether the trunca-
tions affect its function in vivo. The truncated forms were fused
directly to the simu promoter (Figure 5A); we also created MYC-
tagged versions of the truncated forms to directly monitor their
expression level and localization. Both untagged and tagged
truncated versions were placed in the simu mutant background
and assayed for their ability to rescue the phagocytosis defect;
for each transgene, two different genomic insertionswere tested.
As a baseline, we established that the full-length version of the
SIMU protein completely rescues the simu mutant phenotype,
both in its untagged and MYC-tagged form (Figure 5B).
First, we removed the EMI-like domain, whose biological
function has not been established, from SIMU’s N terminus
(SIMUDEMI). SIMUDEMI is properly expressed and localized to
the plasma membrane (data not shown), but does not rescue
the simu mutant phenotype (Figure 5B). This indicates that the
EMI-like domain is essential for SIMU function and for the first
time implicates this type of protein domain in apoptotic clear-
ance. Second, we removed the transmembrane domain and
small intracellular portion from SIMU’s C terminus (SIMUDTM).
We confirmed that SIMUDTM is indeed secreted by S2 cell
transfection (Figure 5C) and in vivo expression, the latter result-
ing in abundant distribution throughout the embryo but with par-
ticular enrichment on macrophage surfaces (Figures 5D and 5E).
Surprisingly, SIMUDTM rescues the simu mutant phenotype al-
most completely, indicating that membrane anchoring is dis-
pensable for SIMU function (Figure 5B). This intriguing result
suggests that the SIMU protein is able to act in two different
modes: as a tethering transmembrane receptor as well as a
secreted bridging molecule.
simu Function Is Epistatic to drpr in the Phagocytosis
of Apoptotic Cells
SIMU’s extracellular domain structure is akin to that of DRPR,
theDrosophila homolog of CED-1 (Figures 6D and 6E), but unlike
SIMU, DRPR is a docking receptor with a long cytoplasmic
domain that contains two conserved tyrosine phosphorylation
sites known to be required for the recruitment of cytoplasmic
factors (Zhou et al., 2001). To further explore the similarity be-
tween SIMU and DRPR, we compared their expression in the
embryo. Similar to simu, drpr is strongly expressed in the
ectoderm, macrophages, and glia (Figures 6A–6C) (Freeman
et al., 2003). Indeed, double labeling of simu-SIMU-MYC and
DRPR antibodies reveals strongly overlapping expression of
the two proteins on the cell surface of macrophages and glia.
Interestingly, the DRPR protein distribution on the plasma mem-
brane is fairly uniform, while SIMU’s appears more patchy
(Figure 6C).
Given the similarities in molecular structure and expression
pattern, we sought to compare the simu and drprmutant pheno-
types. Similar to simu, drpr null mutants are also adult viable. In
our fixed material phagocytosis assay, they show the same
roughly 2-fold increase in the number and volume of apoptotic
particles in the nerve cord as simu mutants (Figures 3C and 3Q)
(Freeman et al., 2003) and the same increase in total particle vol-
ume outside the CNS (Figure 3S). Unlike in simu, however, thereis no significant defect in engulfment: the fraction of untouched
apoptotic particles is the same in drpr mutants as in wild-type
(Figure 3R). Instead, the excess apoptotic particles accumulate
inside the phagocytes (Figures 3G and 3O); this topology is con-
firmed by 3D reconstructions of deep confocal series with appro-
priate cross sections (Figure 4C; compare with Figures 4A, 4B,
and S3). Time-lapse recordings of drprmutants further corrobo-
rate these results. The general searching behavior andmotility of
the phagocytes appear normal, and unlike in simu but similar to
wild-type, few apoptotic particles remain unengulfed or un-
touched. However, apoptotic particles accumulate within the
phagocytes: while in wild-type the majority of phagosomes are
caspase-3-negative and thus appear unlabeled, almost all are
caspase-3-positive in drprmutants (Figure 4G, Movie S3). These
findings indicate that drpr and simu have distinct functions,
with simu involved in recognition and uptake, and drpr primarily
required for the degradation of cell corpses.
To test for interaction between the two genes, we generated
simu; drpr doublemutants. We find the same increase in the total
number and volume of apoptotic particles as in either single mu-
tant (Figures 3D, 3L, 3Q, and 3S); this lack of an additive effect
indicates that simu and drpr act in the same genetic pathway.
Moreover, both fixed material analysis and time-lapse record-
ings show that the simu phenotype is epistatic over that of
drpr. In the simu; drpr double mutant, apoptotic particles accu-
mulate outside the phagocytes, and the fraction of completely
untouched apoptotic particles is the same as in the simu single
mutant (Figures 3H, 3P, 3R, 4D, and 4H; Movie S4). The simu;
drpr double mutant thus closely resembles the simu single
mutant, indicating that simu acts upstream of drpr in the same
phagocytic pathway. These results are rather surprising, since
in the worm, CED-1 is required for the recognition and uptake
as well as for the degradation of apoptotic particles (Yu et al.,
2006; Zhou et al., 2001).
DISCUSSION
In this study, we have demonstrated that tissue-resident clear-
ance by neighboring glia plays a major role in the removal of
apoptotic neurons during nervous system development and
characterized the function of the new tethering receptor SIMU
in this important process.
Using several different markers, we show that, once the nerve
cord is ensheathed and macrophages no longer have access,
astrocytic glia avidly phagocytose apoptotic cells in their vicinity.
This pronounced phagocytic activity is reflected on a molecular
level by a strong differential expression of phagocytosis genes in
the glia. Our in vivo time-lapse recordings indicate that the sta-
tionary glia are as efficient and fast in corpse uptake as the highly
motile macrophages, and differences in clearance are largely a re-
flection of differential motility. Notably, glia also phagocytose axon
branches during neuronal remodeling and injury-inducedWallerian
degeneration (Awasaki and Ito, 2004; Hoopfer et al., 2006;
MacDonald et al., 2006). Collectively, these findings indicate that
glia are potent ‘‘semiprofessional’’ phagocytes and that, at least
during development, tissue-resident apoptotic clearance equals
macrophage-mediated clearance in importance. In vertebrates,
tissue-residentphagocytosisbyneighborshasbeendemonstratedCell 133, 498–509, May 2, 2008 ª2008 Elsevier Inc. 503
Figure 4. Three-Dimensional and Dynamic Analysis of simu and drpr Phenotypes
(A–D) Three-dimensional analysis of engulfment of apoptotic particles (CM1, red) by glia (repo::CD8GFP, green) in the CNS. Shown are single label (glia) and
merged images of local projections of 4–5 mm depth centered around representative individual glia/apoptotic particles, in three orthogonal planes (XY, YZ,
XZ) as indicated; see Experimental Procedures. Note complete engulfment of apoptotic particles in wild-type and drpr, while in simu and in the simu; drpr double
mutant particles are attached but unengulfed, or completely untouched. For additional examples, see Figure S3.504 Cell 133, 498–509, May 2, 2008 ª2008 Elsevier Inc.
Figure 5. Structure-Function Analysis of SIMU Protein
(A) Schematic showing the domain structure of the SIMU protein, the general design of the transgenes (direct fusion to simu promoter; C-terminal MYC-tag) and
the specific deletions made.
(B) Quantification of phenotypic rescue of simu null mutants by the different simu transgenes. Columns represent mean total number of apoptotic particles within
confocal stacks from the neural cortex layer of the CNS, ± SEM, n = 7–12; asterisks indicate statistical significance of comparison with wild-type, as determined
by one-way ANOVA with Student-Newmann-Keuls post hoc test, ***p < 0.001, n.s. (not significant) p > 0.05.
(C)Western blot analysis of transfected S2 cells showing that SIMU lacking the transmembrane domain (SIMUDTM) is secreted, while full-length SIMU is retained
in the cells.
(D–F) In vivo distribution of GFP-tagged SIMU (green) expressed under a longitudinal glial-specific driver (tgl-Gal4). Full-length SIMU is found only on the surface
of expressing cells (D), while the secreted SIMUDTM is found throughout the embryo (E), with accumulation on the surface of CRQ-positive (red) macrophages
(arrowheads) and the ectoderm. This accumulation is also found in drpr null embryos (F); both single-label and merged images are shown.in vivo in some contexts including glia (Hanayama and Nagata,
2005; Nakanishi and Shiratsuchi, 2004; Parnaik et al., 2000;
Wood et al., 2000), but its overall contribution to apoptotic
clearance and the underlying molecular mechanisms have not
been established (Henson and Hume, 2006).
Our investigation of the gene simu was originally motivated
by two intriguing features: its expression during all major epochs
of developmental apoptosis and in the major phagocytic cell
types—in particular the glia—and a protein domain structure
that is similar to but distinct from that of the CED-1 homolog
DRPR. The two proteins are expressed in strongly overlapping
patterns throughout embryogenesis and largely colocalize at
the plasma membrane of glia and macrophages. Our genetic
analysis now reveals that they are components of the same
phagocytic pathway, with simu acting upstream of drpr. Obser-
vations both in fixed material and in time-lapse recordings show
simu affecting the early steps of recognition and engulfment of
apoptotic particles, while drpr affects their subsequent degrada-
tion; the double-mutant phenotype closely resembles that of
simu alone, indicating epistasy of simu over drpr. Unlike DRPR,
SIMU lacks a large cytoplasmic domain with docking sites for
downstream effectors, and our results suggest that its molecularfunction is to recognize the apoptotic cell and tether it to the
phagocyte. Purified SIMU protein strongly binds to apoptotic
cells in vitro; the in vivo analysis indicates that the N-terminal
EMI-like domain, which is essential for SIMU function, is likely in-
volved in the recognition and binding. To date, EMI domains
have only been implicated in protein-protein interaction, sug-
gesting that SIMU may recognize a protein rather than a lipid
or carbohydrate component on the apoptotic cell. The lack of
a cytoplasmic domain and the dispensability of membrane
anchoring for in vivo function imply that SIMU must interact,
directly or indirectly, with docking receptors on the phagocyte
surface to effect engulfment and subsequent degradation. Given
its phenotype and action downstream of simu, drpr is the prime
candidate for mediating degradation. However, the difference in
the simu and drpr phenotypes (in particular the essentially unim-
paired engulfment of apoptotic particles we observe in drpr
mutants) strongly argues for the existence of an intermediary
factor that controls the cytoskeletal reorganization necessary
for engulfment downstream of simu. The existence of a SIMU
binding partner other than DRPR is supported by our finding
that, in drpr null mutants, secreted SIMUDTM still accumulates
on macrophage cell surfaces (Figure 5F), and by the fact that(E–H) Time-lapse recordings of phagocytosis in stage 16 embryos. Glia and macrophages are labeled with simu-cytGFP (green), apoptotic cells with the fluo-
rogenic caspase-3 substrate Phiphilux (red); selected consecutive frames are shown (movies are available in the Supplemental Data); enlarged view of
individual macrophages over two consecutive frames is shown at bottom, with origin indicated by dotted boxes. In wild-type (E), nearly all apoptotic particles
are touched or engulfed (circles); in simu mutants (F), many apoptotic particles are untouched (arrowheads) or remain on the phagocyte cell surface (arrows);
in drprmutants (G), apoptotic particles accumulate inside the phagocytes (circles); in the simu; drpr double mutant (H), particles accumulate outside the phago-
cytes, similar to the simu single mutant.Cell 133, 498–509, May 2, 2008 ª2008 Elsevier Inc. 505
we observe no physical interaction between SIMU and DRPR in
coimmunoprecipitation experiments (data not shown). Thus, the
following model seems most likely: As part of a linear pathway,
SIMU interacts with a factor X, leading to the recruitment of cy-
toskeletal components for engulfment and phagosome forma-
tion, followed by X interacting with DRPR, which leads to the
recruitment of degradation components for phagosomematura-
tion. The identification of factor X and its extra- and intracellular
binding partners will be the subject of future investigation, and
understanding the mechanisms by which the different phago-
cytic receptors cluster and coordinate their function will be of
particular interest.
The existence of the SIMU protein was unexpected both ge-
nomically and genetically: the C. elegans genome does not con-
tain a SIMU homolog and in fact no other EMI(-like)+NIM domain
protein. Moreover, in contrast to drpr, CED-1 is crucial for recog-
nition, engulfment, and the degradation of corpses in the worm
(Yu et al., 2006; Zhou et al., 2001), suggesting that biological
functions that are performed by a single factor in the worm
become distributed among more specialized proteins in the fly.
Intriguingly, when the worm CED-1 mutant is rescued by a trans-
gene that lacks the intracellular docking domain, recognition and
engulfment, but not degradation, are restored, resulting in a drpr-
like phenotype (Zhou et al., 2001). Several recent papers have
suggested that DRPR acts as an engulfment receptor in different
developmental contexts in the fly (Awasaki et al., 2006; Freeman
et al., 2003; Hoopfer et al., 2006; Li and Baker, 2007; MacDonald
et al., 2006).Most observed an increase in the number of apopto-
tic cells or axon fragments in drpr mutants, which is consistent
with our findings. Unlike our analysis, however, none of these
studies established whether the excess apoptotic particles
Figure 6. Comparison of the SIMU and DRPR Proteins
(A–C) In vivo expression patterns, showing strong overlap be-
tween SIMU (visualized by simu-SIMU-MYC; green) and
DRPR (anti-DRPR antibody; red) in glia and macrophages;
magnification of boxed areas at right bottom, showing strong
colocalization of the two proteins at the cell surface.
(D) Schematic representation of domain organization of SIMU
and of the two isoforms of DRPR.
(E) Sequence alignment of the N-terminal EMI(-like)+NIM do-
main of DRPR and SIMU; identical residues are boxed in
black, similar residues in gray. The EMI-like domain in SIMU
lacks two internal cysteines that are present in DRPR
(arrowheads), but has both the first cysteine and the highly
conserved CCxGY motif. See also Figure S2.
accumulate outside or inside the respective phago-
cytes. It is also noteworthy that apoptotic clearance
is much faster (minutes versus hours or days) than
axon pruning/Wallerian degeneration and possibly
involves distinct signals from the degrading cells
(caspase versus non-caspase-mediated mecha-
nism) (Awasaki and Ito, 2004; Finn et al., 2000;
Watts et al., 2003), making it likely that differences
exist at the level of the recognition factors.
The comparison of apoptotic clearance in worm,
fly, and vertebrate provides interesting evolutionary
perspectives. Between worm and fly, the demand for apoptotic
clearance increases both in quantitative and qualitative terms:
During worm development, only 10% of cells are fated to die,
and they are removed shortly after their birth through phagocyto-
sis by immediate neighbors, apparently without need for dedi-
cated phagocytes (Lettre and Hengartner, 2006). During fly de-
velopment, a much larger proportion of cells die through
apoptosis (>30%) (Abrams et al., 1993; Rogulja-Ortmann et al.,
2007), and their death is spread out over a wide range of stages
in their life cycle: immediately after their birth, during fating and
differentiation, and even after long-term function (Truman et al.,
1992). To meet this challenge, macrophages emerge as profes-
sional phagocytes, and in addition, several cell types differen-
tially increase their phagocytic capacity and become semipro-
fessional phagocytes, including the ectoderm and the glia. In
vertebrates, the apoptotic load is presumably even greater (Hen-
son and Hume, 2006; Jacobson et al., 1997), and the cellular
complexity of the innate immune system is of course greatly in-
creased. Strikingly, these changes are accompanied by an in-
crease in complexity at the molecular level, both in terms of
a greater structural diversity of phagocytic receptors generally
and of CED-1-like factors in particular. While C. elegans seems
to have only one CED-1 gene encoding a single protein form,
Drosophila has two different DRPR isoforms with distinct extra-
cellular domains and the entire Nimrod gene family, including
SIMU and Eater (Kurucz et al., 2007). This family contains both
secreted and transmembrane proteins, and receptors for the
clearance of apoptotic cells (SIMU) and pathogens (Eater, NIM
C1), but the function of most family members is not known. The
in vivo function of the vertebrate CED-1-like factors is also un-
known, but cell culture experiments suggest that MEGF10 is506 Cell 133, 498–509, May 2, 2008 ª2008 Elsevier Inc.
a phagocytic receptor for apoptotic cells and SREC for (oxidized)
LDL (Adachi et al., 1997;Hamon et al., 2006). Themolecular com-
parisons indicate that thesephagocytic factors all share anN-ter-
minal EMI(-like)+NIM core, presumably for recognition, and that
invertebrates and vertebrates amplified different EGF-type re-
peats present in the ancestral CED-1 (Figure S2), either to
achieve appropriate spacing or to facilitate homotypic cis inter-
action in factor clustering.
This molecular expansion is likely accompanied by an in-
crease in functional redundancy between phagocytic pathways:
already in theworm, at least two (CED-1/6/7 andCED-2/5/10/12)
and likely a third (currently unknown) pathway participate in the
phagocytosis process (Mangahas and Zhou, 2005; Reddien
and Horvitz, 2004). As shown here for the fly, joint removal of
simu and drpr results in viable adults whose apoptotic clearance
is impaired but not abrogated, indicating the existence of addi-
tional as-yet-unidentified pathways. Finally, in vertebrates,
a large number of different types of macrophage receptors
have been identified, which under single-mutant conditions ei-
ther only reduce apoptotic clearance or have no effect at all
(Grimsley and Ravichandran, 2003; Platt and Gordon, 2001;
Scott et al., 2001; Stuart and Ezekowitz, 2005).
Overall, our study has shown that the differences between
professional and nonprofessional phagocytes are perhaps
more fluid than originally thought. Not only can tissue-resident
phagocytic cells differentially upregulate a similar molecular rep-
ertoire of phagocytic pathways, but they also can use it as
quickly and efficiently as the macrophages when confronted
with apoptotic neighbors. This suggests a simple division of la-
bor: In freely accessible spaces, actively patrollingmacrophages
clear the corpses, while in sequestered spaces—such as the late
nervous system—the task falls to resident neighbors like the glia.
In addition to its role in development, the efficient clearance of
apoptotic cells is essential for avoiding secondary necrosis and
exposure of cytoplasmic components to the immune system,
acutely causing inflammation and, chronically, autoimmune dis-
ease. While apoptotic clearance by tissue-resident cells has
received relatively little attention in vertebrate research, its com-
prehensive analysis in genetic models such as the fly will con-
tinue to provide new and interesting insight into the underlying
cellular and molecular mechanisms.
EXPERIMENTAL PROCEDURES
Fly Strains and Molecular Biology
The following fly strains were obtained from published sources: repo-Gal4
(V. Auld); crq::cytGFP (P. Martin; gift from H. Agaisse and N. Perrimon); UAS-
CD8GFP (L. Luo); Df(2L)Sco7 (#6069; Bloomington); prd-Gal4 (#1947; Bloo-
mington);drprD5 (M.Freeman); andDf(3L)H99 (H.Steller). Adetaileddescription
of all constructs generated for this study is available upon request, in-
cludingUAS-mRFP,UAS-SIMU-GFP, simu-cytGFP, simu-SIMUDEMI-(4xMyc),
simu-SIMUDTM-(4xMyc), HIS-MYC-SIMUDTM, and the simu null pTV2-target-
ing construct.
For the genomic knockout, we assembled a contiguous 7.1 kb piece of ge-
nomic DNA containing the simu coding region, in which stop codon mutations
and restriction sites (EcoRI, StuI, I-SceI) had been introduced by PCR (Rong
and Golic, 2000; Rong et al., 2002) and placed into pTV2. Using two different
genomic insertions of the donor construct (X, III), we recovered 3 and 14
targeted events, respectively, from 500,000 screened flies; from both screens,
single-copy reduction events carrying the engineered mutations were recov-ered and confirmed by PCR and Southern blot analysis. Northern and South-
ern analyses were carried out using standard protocols and RNA in situ hybrid-
ization according to http://www.fruitfly.org/about/methods/RNAinsitu.html.
Immunohistochemistry and Imaging
Drosophila Schneider (S2) cells were transfected using cellfectin (Invitrogen)
and plated on poly-L-lysine (Sigma) coated slide chambers. Immunohisto-
chemistry followed standard procedures using mouse anti-GFP (Molecular
Probes; 1:50), mouse anti-MYC (Santa Cruz, 1:200), rat polyclonal anti-CRQ
(Nakanishi; 1:100), mouse anti-REPO (Developmental Studies Hybridoma
Bank; 1:5), rabbit anti-DRPR (Freeman; 1:500), and rabbit anti-activated
caspase-3 (CM1; Cell Signaling Technology; 1:25). Fluorescent secondary
antibodies were diluted 1:200 (Cy3 Jackson ImmunoResearch; Alexa Fluor
488 Molecular Probes). Live imaging was carried out by dechorionating em-
bryos (stage 16), mounting them under halocarbon oil, injecting 2%–3% egg
volume AnnexinV (Molecular Probes) or LysoTracker (Molecular Probes;
1:10) and imaging after 30–60 min incubation. All confocal images were ac-
quired using a Zeiss LSM 510 system. Image analysis was performed using
Zeiss LSM 510 and Imaris (Bitplane) software.
Phagocytosis Assays
To quantitate the number of apoptotic particles and their engulfment by glia,
confocal stacks (6 sections; total 3 mm) were acquired from the neural cortex
of stage 16 ventral nerve cords, where most apoptosis occurs and where cell
body glia reside. To quantitate the number of apoptotic particles outside the
CNS, stage 14 embryos were imaged from lateral to medial, excluding the
nerve cord (confocal stacks with 50 sections; total 43 mm). Three-dimensional
reconstructions were built and the number and volume of CM1-positive parti-
cles measured with an appropriate isosurfacing threshold using Imaris
software. The percentage of completely untouched particles was determined
by analyzing the relative position of glia to apoptotic cells. All data were col-
lected with identical microscope and software parameter settings. Statistical
significance of differences between experiments was assessed by one-way
ANOVA with Student-Newman-Keuls post hoc test, with n = 7–12 for the
CNS analysis and n = 5–9 for the whole embryo analysis. The number of glial
cells and macrophages was assessed using confocal stacks of similar origin
and size as described above (glia labeled with anti-REPO, macrophages
labeled with crq::cytGFP) andmanual or computer-assisted (Imaris) cell count-
ing; results are reported as mean ± SD, n = 6. The high-resolution 3D analysis
of the engulfment of CM1-positive particles by glia was performed using deep
confocal stacks of stage 16 ventral nerve cords (30 sections, total 15 mm)
and the Imaris section tool.
For time-lapse recordings, simu-cytGFP embryos were injected with 1%
egg volume of 10 mM Phiphilux (OncoImmunin) and imaged on a Zeiss LSM
510 system using an Apochromat 403water immersion objective, taking con-
focal stacks (8 sections, total 7 mm) at 90–150 s intervals. NIH ImageJ software
was used to process the images and generate maximum-intensity projections
of the stacks.
To test for heterologous induction of phagocytosis, COS7 cells were tran-
siently cotransfected with pCDNA-Gal4 and UAS-cytGFP (negative control;
Clontech), UAS-CRQ (positive control; K. White) or UAS-SIMU. To obtain
apoptotic cells, COS7 cells were treated 16 hr with 75 mM etoposide and la-
beled with DiI (Molecular Probes). Seventy hours after transfection, the trans-
fected COS7 cells were incubated with apoptotic COS7 cells (1:5 ratio; 1.5 hr),
washed (33 cold PBS), trypsinized, and analyzed by flow cytometry. Trans-
fected and apoptotic cells were distinguished by different FSC and SSC. For
each experiment, 10,000 events were collected and the data were analyzed
using Cell Quest and FlowJo software. Experiments were repeated four times,
with similar results.
Simu Protein Purification and Binding to Apoptotic Cells
The extracellular portion of SIMU (residues 19–322) was cloned into a
HIS-MYC-tag containing vector (pCEP-Pu; Thur et al., 2001), stably trans-
fected into HEKc18 cells using Fugene 6 reagent (Roche) and puromycin se-
lection; the tagged protein was affinity-purified from supernatant using TALON
metal affinity beads (Clontech) according to manufacturer’s specifications. To
induce apoptosis, S2 cells were treated with 75 mM etoposide for 16hr. SixCell 133, 498–509, May 2, 2008 ª2008 Elsevier Inc. 507
micrograms of purified HIS-MYC-SIMU-DTMwere incubated with live and ap-
optotic S2 cells (PBS +1% NHS; 1.5 hr). Cells were then incubated with anti-
MYC Ab (Santa Cruz Biotechnology; 1:100; 1 hr) and fluorescent secondary
Ab (Alexa Fluor 488—anti-mouse; Molecular Probes; 1:400; 40 min) and ana-
lyzed by flow cytometry. For each experiment, 10,000 events were collected
and the data were analyzed using Cell Quest and FlowJo software. Experi-
ments were repeated three times, with similar results.
SUPPLEMENTAL DATA
Supplemental Data include three figures, Supplemental References, four
movies, and can be found online at http://www.cell.com/cgi/content/full/
133/3/498/DC1/.
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